Literature DB >> 11234912

Kleptomania in a patient with a right frontolimbic lesion.

T Nyffeler1, M Regard.   

Abstract

OBJECTIVE: The authors report the case of a patient in whom kleptomania developed in the course of a right frontolimbic behavior syndrome after undergoing surgery.
BACKGROUND: Kleptomania is a behavior abnormality that is classified as an impulse-control disorder; however, little is known about its organic correlates.
METHOD: History included neurologic data, neuropsychological data, electroencephalographic data, and magnetic resonance images.
RESULTS: Observation of kleptomania associated with a large sellar craniopharyngioma with right-sided extension suggests that the site of a lesion may be crucial for the development of an impulse-control disorder.
CONCLUSIONS: The authors discuss kleptomania in the context of functional deficits associated with damage to orbitofrontal-subcortical circuits, and they suggest that kleptomania is a neuropsychiatric symptom that can be conceptualized as being an uncommon compulsive display of impulse dyscontrol.

Entities:  

Mesh:

Year:  2001        PMID: 11234912

Source DB:  PubMed          Journal:  Neuropsychiatry Neuropsychol Behav Neurol        ISSN: 0894-878X


  4 in total

Review 1.  The frontal cortex and the criminal justice system.

Authors:  Robert M Sapolsky
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-11-29       Impact factor: 6.237

2.  White matter integrity in kleptomania: a pilot study.

Authors:  Jon E Grant; Stephen Correia; Thea Brennan-Krohn
Journal:  Psychiatry Res       Date:  2006-09-07       Impact factor: 3.222

Review 3.  Kleptomania: Recent Advances in Symptoms, Etiology and Treatment.

Authors:  Zi-Hao Zhang; Fu-Rong Huang; Deng-Hua Liu
Journal:  Curr Med Sci       Date:  2018-10-20

4.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.